dorsaVi Ltd engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States. It operates through two segments: Clinical and Workplace. The company provides ViMove+, a clinical and sports solutions; ViSafe, a wearable sensor technology that analyzes how workforce moves and reviews and pinpoints unsafe work practices that leads to workplace injury; and myViSafe technology for organizations and on-site clinicians to identify and mitigate injury risk in the workplace and drive behavioral changes. It also offers ViPerform, a wearable and wireless movement sensor technology that offers objective data to assess risk of sport injury and guides athletic training and recovery programs; telehealth solutions; and professional suites. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Melbourne, Australia.
Visit company website
5 years, 5 months ago
dorsaVi Ltd is currently in a long term downtrend where the price is trading 11.2% below its 200 day moving average.
From a valuation standpoint, the stock is 92.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 5.4.
dorsaVi Ltd's total revenue sank by 35.0% to $820K since the same quarter in the previous year.
Its net income has increased by 94.4% to $-327K since the same quarter in the previous year.
Finally, its free cash flow grew by 69.3% to $-316K since the same quarter in the previous year.
Based on the above factors, dorsaVi Ltd gets an overall score of 3/5.